ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: Board Advocates $2 Per Pack Raise For Cigarettes

January 16, 1998

Program Project Guidelines Available

October 27, 1995

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013

In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision

November 5, 1999

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001

In Brief: NCI Deputy Director Ihde To Leave Institute; Bynum To Retire; Lewis Thomas Dead At 80

December 10, 1993